Competitive Landscape Assessment

Opportunities in dissolvable Microneedle Technology (dMTS) space

Expanding product offering by assessing novel technologies

Problem Statement:

A large medical device client, based in the United States, with capabilities in drug delivery medical devices, involved DelveInsight to assess the potential risks and benefits of a merger being evaluated to further the goal of becoming market leaders in the niche area of drug delivery through a novel technology (dissolvable microneedle technology) for drug delivery. The client wanted to include certain intellectual property in their portfolio through this deal, but was concerned about impact of the merger in their overall business strategy.

  • Provided steps to retain control of major strategy centric processes to allay post-merger dissolution risks
  • Assessed Company’s exposure to post-merger impacts, and provided remedial solutions to combat such situations
  • Understanding Manufacturing and Import Licensing ProcessProvision of safeguards to each entity during the transition to keep the process in control
  • Executed workshops to retain transparency during and after the merger
Our Methodology:
  • Evaluation of the dissolvable microneedle technology space to find entities with good technology and IP
  • Understanding best partner through assessment of overall strategies of merging entities'
  • Deep-dive assessments into the compatibility aspect of the two firms to ensure cohesion
  • Analysis of Transactional costs relating to the merger
  • Descriptive understanding of the post-merger environment
  • Created a new niche for the client in the Drug delivery space with addition of a novel technology
  • Helped retain the client’s competitive position in the market
  • Led to proper allocation of research resources for future commercial goals

Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset... [...]

View Case
Out Licensing Opportunity
Out-Licensing Opportunity

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.